Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is among the must-buy penny stocks to invest in now. Recursion Pharmaceuticals ...
Recursion Pharmaceuticals expanded its collaboration with Citeline to integrate real world data into its AI enabled ClinTech Platform. The partnership is aimed at refining clinical trial design and ...
Recursion Pharmaceuticals executives discussed the company’s artificial intelligence-driven drug discovery platform during a ...
Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...
7dOpinion
AI needs a reality check
You can bring initial model predictions closer to reality by training those AI models on rich patient data. The more detailed ...
While the advent of artificial intelligence (AI) has obviously changed the world, not every utilization of AI has necessarily ...
Opinion
1dOpinion
To be human is to live with friction. That’s something AI boosters will never understand
We’re being sold a world where there’s no room for reflection or spontaneity. This is the Black Mirror stage of capitalism, says Alexander Hurst, who writes for Guardian Europe from Paris ...
With an IPO raise of $625 million, Kailera Therapeutics now holds the new record for the largest public market debut.
AI is forcing a measurement crisis we’ve avoided for 100 years. If AI can write our emails, analyze data, and generate code, ...
OpenAI is rolling out an early version of an artificial intelligence model designed to accelerate drug discovery, joining a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results